We use cookies for a better user experience. Read our Privacy Policy

I Agree

Organoids Market

Organoids Market (Type: Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others; Application: Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery & Personalized Medicine, and Others; and Source: Pluripotent Stem Cells [hIPSCs] and Organ-speci?c Adult Stem Cells [ASCs]) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Increasing Demand for Gene Mutation and Cancer Research to Drive Market

Over the past decade, organoids are being increasingly used in a range of applications, including disease modeling, pathogenesis, drug screening, and regenerative medicine, and the trend is set to continue during the forecast period. Organoid technologies have witnessed considerable developments in recent years, and continue to pave the way for the development of in vitro physiologic systems that model the origin tissues with high degree of accuracy compared to conventional approaches. The increasing focus on research and development activities is expected to play a key role in the development of the global organoids market during the assessment period.

The capability of 3D-organoid cultures to mimic organ functionality to some degree is one of the key factors likely to establish organoids as an ideal model for applications such as stem cell research to precision medicine. Furthermore, the increasing adoption of the organoid technology for use in a range of applications, including genetic mutation, gene assessment, and tumor modelling is expected to accelerate the overall development of the global organoids market during the assessment period. The assessment of different diseases by leveraging the organoid technology is anticipated to remain one of the most prominent applications of organoids in the upcoming years.

At the back of these factors coupled with the consistent rise in the investment for research and development, the global orgnoids market is expected to cross the market value of US$ 12.8 Bn by the end of 2030.

Request a sample to get extensive insights into the Organoids Market

Increasing Demand for Tumor Modelling and Biobanking to Propel Market Growth

The consistent progress in the organoid technology has gradually paved the way for ‘tumouroids’ and patient-centric 3D cultures of cells that are isolated from tumor biopsies. Over the past few decades, tumouroid lines have been established from a plethora of cancer types such as liver, breast, prostate, brain, bladder, and more from metastasis as well as primary tumors. Due to consistent advancements, in the current scenario, tumouroid lines are increasingly being passed in vitro, which opens up new avenues for a range of downstream applications. Moreover, 3D-based cultures offer additional advantages over the conventional 2D cancer-derived cell lines. Moreover, research and development activities have indicated that tumouroid culturing is highly efficient in enabling the collection of various cancer subtypes from a large pool of patients. As organoids can be easily derived and expanded from single cancer cells, the adoption of organoids to mimic intratumour diversification in culture is on the rise– a factor that is projected to propel the global organoids market during the assessment period.

To understand how our report can bring difference to your business strategy, Ask for a brochure

New Discoveries Driven by Research & Development to Boost Prospects

Research and development activities are set to play a key role in the overall development of the global organoids market during the assessment period. In addition, increasing collaborations between researchers and medical experts are anticipated to accelerate the development of complex organoids. For instance, two recent discoveries are expected to boost the overall prospects of next-generation organoid development. The new research collaboration between a team of scientists from the Cincinnati Children’s and Japan was announced in August 2020. As per the research team, discoveries from the new research collaboration are likely to be one of the most critical aspects for the development of a new wave of complex organoids. Although the organoid technology has progressed at a consistent pace over the past few years, the application of the same continues to remain sluggish in the current scenario. However, increasing focus on the commercialization of organoids and consistent progress in genome editing techniques are expected to bolster the growth of the global organoids market during the assessment period.

Demand for Human and Animal Organoids on Rise amid COVID-19 Pandemic

The advent of the novel COVID-19 pandemic is anticipated to open up new opportunities for the players involved in the current organoids market landscape. While researchers continue to assess the biology of the novel coronavirus, human and animal organoids are gradually anticipated to prove their value as an experimental virology platform. Furthermore, several researchers from various regions of the world have turned toward organoid technologies to assess the tissue tropism of the novel SARS-COV-2 virus.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Organoids Market

Analysts’ Viewpoint

The global organoids market is projected to expand at a high CAGR during the assessment period. Increasing prevalence of several diseases, outbreak of the novel COVID-19 pandemic, and rising adoption of organoids for disease modelling, gene mutation, and tumor modelling, advancements in organoid technology, and research and development activities are some of the key factors that are likely to drive the global organoids market during the assessment period. Furthermore, the increasing adoption of organoids as an ideal tool for respiratory infections and diseases will bolster the growth of the global organoids market during the assessment period.

Organoids Market: Overview

  • The global organoids market was valued over US$ 1.7 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Increase in incidence and prevalence of chronic and infectious diseases, adoption of organoids as therapeutics tools, application of organoids in drug discovery & personalized medicine, and use of organoids in research & development is anticipated to propel the global organoids market. The globe market is driven by the application of organoids as an important tool for cell biology, gene therapy, regenerative medicine, cancer research, and disease modelling. Technological advancements are expected to propel the global organoids market during the forecast period.
  • Organoids are miniature, self-organized three-dimensional culture derived from stem cells, including pluripotent stem cells and adult stem cells. Organoids are considered replication of complex organs such as stomach, intestine, brain, kidney, lungs, and liver. Organoids are grown from stem cells of different sources, and these cells divide indefinitely and produce different types of cells. These structures resemble the miniature organs, which range from size of a hair width to five millimeters.
  • Organoids provide scientists a detailed understanding and view about the organ growth and formation, and offer them promising approach about the disease pathology and human development. Scientists have found organoids to be potential mini organs in the drug discovery and personalized medicine.                                                                                      

Organoids Market: Segmentation

  • The global organoids market has been segmented based on type, application, source, and region
  • In terms of type, the global organoids market has been classified into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment accounted for a prominent share of the market in 2019, ascribed to rise in prevalence of inflammatory bowel diseases (IBD) across the globe. For instance, the inflammatory bowel disease (IBD) has affected 300 per 100,000 people across the world.
  • Based on application, the global organoids market has been categorized into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology segment accounted for a major share of the market in 2019, owing to its consideration as primary investigative research tool of the human developmental biology. Moreover, organoids derived from embryonic stem cells offer complete understanding of the embryonic process development and insights on development of the stem cells.
  • In terms of source, the global organoids market has been bifurcated into pluripotent stem cells (hIPSCs) and organ-specific adult stem cells (ASCs). The pluripotent stem cells (hIPSCs) segment dominated the global organoids market in 2019, as pluripotent stem cells are preferred for the ability to divide indefinitely for conducting basic research and has wide therapeutic applications.

Organoids Market: Regional Segmentation

  • In terms of region, the global organoids market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global organoids market in 2019. This can be ascribed to rise in patients suffering from various diseases, increase in investment in research & development, commercialization of organoid models, and stem cell research.
  • The market in Europe is likely to grow at a rapid pace during the forecast period. Development of cerebral organoids for neurological diseases and rise in prevalence of infectious and other diseases are projected to drive the organoids market in the region over the next few years. Investments in research & development on cancer, liver diseases, gastrointestinal diseases for organ regeneration, and stem cell research are likely to augment the organoids market in Europe during the forecast period.

Organoids Market: Major Players

  • Key players operating in the global organoids market include
    • STEMCELL Technologies, Inc.
    • Cellesce Ltd.
    • Hubrecht Organoid Technology
    • Definigen
    • 3Dnamics, Inc.
    • Organoid Therapeutics
    • PeproTech, Inc.
    • Thermo Fisher Scientific
    • Corning Incorporated (Life Sciences)
    • Merck KGgA
  • These players focus on adopting various strategies to expand product offerings and to strengthen the geographic presence across the globe. These have incorporated diverse strategies, including adoption of technological advancements, commercialization of organoids technology, alliances with universities and companies, ongoing studies related to different organoids, merger & acquisitions, and innovation to boost presence across the globe. Moreover, rise in disease prevalence across the globe would prompt companies to initiate awareness campaigns regarding the adoption of organoids for research & development, which, in turn, is projected to augment the global organoids market.

Organoids Market – Segmentation

Type

  • Stomach
  • Intestine
  • Liver
  • Pancreas
  • Lung
  • Brain
  • Kidney
  • Others

Application

  • Developmental Biology
  • Disease Pathology of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity and Efficacy Testing
  • Drug Discovery & Personalized Medicine
  • Others

Source

  • Pluripotent Stem Cells (hIPSCs)
  • Organ-speci?c Adult Stem Cells (ASCs)

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Organoids Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of organoids market?

Organoids market is expected to cross the market value of US$ 12.8 Bn by the end of 2030

What is the anticipated CAGR of the organoids market in the forecast period?

Organoids market is projected to expand at a high CAGR from 2020 to 2030

What are the key driving factors for the growth of the organoids market?

Organoids market is driven by rising adoption of organoids for disease modelling, gene mutation, and tumor modelling, advancements in organoid technology, and research and development activities

Which is the rising prominent segment in the organoids market?

The developmental biology segment accounted for a major share of the organoids market, owing to its consideration as primary investigative research tool of the human developmental biology

Who are the key players in the global organoids market?

Key players operating in the global organoids market include STEMCELL Technologies Inc., Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, PeproTech, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Organoids Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Organoids Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Regulatory Scenario by Region/globally

    5.2. Disease Prevalence & Incidence Rate globally with key countries

    5.3. Technological Advancements

    5.4. COVID-19 Pandemic Impact on Global Organoids Market

6. Global Organoids Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Organoids Market Value Forecast, by Type,2018–2030

        6.3.1. Stomach

        6.3.2. Intestine

        6.3.3. Liver

        6.3.4. Pancreas

        6.3.5. Lung

        6.3.6. Brain

        6.3.7. Kidney

        6.3.8. Others

    6.4. Market Attractiveness Analysis, by Type

7. Global Organoids Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Organoids Market Value Forecast, by Application, 2018–2030

        7.3.1. Developmental Biology

        7.3.2. Disease Pathology of Infectious Disease

        7.3.3. Regenerative Medicine

        7.3.4. Drug Toxicity & Efficacy Testing

        7.3.5. Drug Discovery & Personalized Medicine

        7.3.6. Others

    7.4. Global Organoids Market Attractiveness Analysis, by Application

8. Global Organoids Market Analysis and Forecast, by Source

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Organoids Market Value Forecast, by Source, 2018–2030

        8.3.1. Pluripotent Stem Cells (hIPSCs)

        8.3.2. Organ-speci?c Adult Stem Cells (ASCs)

    8.4. Global Organoids Market Attractiveness Analysis, by Source

9. Global Organoids Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Organoids Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Organoids Market Attractiveness Analysis, by Region

10. North America Organoids Market Analysis and Forecast

    10.1.  Introduction

        10.1.1.  Key Findings

    10.2. North America Organoids Market Value Forecast, by Type,2018–2030

        10.2.1. Stomach

        10.2.2. Intestine

        10.2.3. Liver

        10.2.4. Pancreas

        10.2.5. Lung

        10.2.6. Brain

        10.2.7. Kidney

        10.2.8. Others

    10.3. North America Organoids Market Value Forecast, by Application, 2018–2030

        10.3.1.  Developmental Biology

        10.3.2. Disease Pathology of Infectious Disease

        10.3.3. Regenerative Medicine

        10.3.4. Drug Toxicity & Efficacy Testing

        10.3.5. Drug Discovery & Personalized Medicine

        10.3.6. Others

    10.4. North America Organoids Market Value Forecast, by Source, 2018–2030

        10.4.1. Pluripotent Stem Cells (hIPSCs)

        10.4.2. Organ-speci?c Adult Stem Cells (ASCs)

    10.5. North America Organoids Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Organoids Market Attractiveness Analysis

        10.6.1. By Type

        10.6.2. By Application

        10.6.3. By Source

        10.6.4. By Country

11. Europe Organoids Market Analysis and Forecast

    11.1. Introduction

        11.1.1.  Key Findings

    11.2. Europe Organoids Market Value Forecast, by Type,2018–2030

        11.2.1. Stomach

        11.2.2. Intestine

        11.2.3. Liver

        11.2.4. Pancreas

        11.2.5. Lung

        11.2.6. Brain

        11.2.7. Kidney

        11.2.8. Others

    11.3. Europe Organoids Market Value Forecast, by Application, 2018–2030

        11.3.1.  Developmental Biology

        11.3.2. Disease Pathology of Infectious Disease

        11.3.3. Regenerative Medicine

        11.3.4. Drug Toxicity & Efficacy Testing

        11.3.5. Drug Discovery & Personalized Medicine

        11.3.6. Others

    11.4. Europe Organoids Market Value Forecast, by Source, 2018–2030

        11.4.1. Pluripotent Stem Cells (hIPSCs)

        11.4.2. Organ-speci?c Adult Stem Cells (ASCs)

    11.5. Europe Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Organoids Market Attractiveness Analysis

        11.6.1. By Type

        11.6.2. By Application

        11.6.3. By Source

        11.6.4. By Country/Sub-region

12. Asia Pacific Organoids Market Analysis and Forecast

    12.1. Introduction

        12.1.1.  Key Findings

    12.2. Asia Pacific Organoids Market Value Forecast, by Type,2018–2030

        12.2.1. Stomach

        12.2.2. Intestine

        12.2.3. Liver

        12.2.4. Pancreas

        12.2.5. Lung

        12.2.6. Brain

        12.2.7. Kidney

        12.2.8. Others

    12.3. Asia Pacific Organoids Market Value Forecast, by Application, 2018–2030

        12.3.1.  Developmental Biology

        12.3.2. Disease Pathology of Infectious Disease

        12.3.3. Regenerative Medicine

        12.3.4. Drug Toxicity & Efficacy Testing

        12.3.5. Drug Discovery & Personalized Medicine

        12.3.6. Others

    12.4. Asia Pacific Organoids Market Value Forecast, by Source, 2018–2030

        12.4.1. Pluripotent Stem Cells (hIPSCs)

        12.4.2. Organ-speci?c Adult Stem Cells (ASCs)

    12.5. Asia Pacific Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Organoids Market Attractiveness Analysis

        12.6.1. By Type

        12.6.2. By Application

        12.6.3. By Source

        12.6.4. By Country/Sub-region

13. Latin America Organoids Market Analysis and Forecast

    13.1. Introduction

        13.1.1.  Key Findings

    13.2. Latin America Organoids Market Value Forecast, by Type,2018–2030

        13.2.1. Stomach

        13.2.2. Intestine

        13.2.3. Liver

        13.2.4. Pancreas

        13.2.5. Lung

        13.2.6. Brain

        13.2.7. Kidney

        13.2.8. Others

    13.3. Latin America Organoids Market Value Forecast, by Application, 2018–2030

        13.3.1.  Developmental Biology

        13.3.2. Disease Pathology of Infectious Disease

        13.3.3. Regenerative Medicine

        13.3.4. Drug Toxicity & Efficacy Testing

        13.3.5. Drug Discovery & Personalized Medicine

        13.3.6. Others

    13.4. Latin America Organoids Market Value Forecast, by Source, 2018–2030

        13.4.1. Pluripotent Stem Cells (hIPSCs)

        13.4.2. Organ-speci?c Adult Stem Cells (ASCs)

    13.5. Latin America Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Organoids Market Attractiveness Analysis

        13.6.1. By Type

        13.6.2. By Application

        13.6.3. By Source

        13.6.4. By Country/Sub-region

14. Middle East & Africa Organoids Market Analysis and Forecast

    14.1. Introduction

        14.1.1.  Key Findings

    14.2. Middle East & Africa Organoids Market Value Forecast, by Type,2018–2030

        14.2.1. Stomach

        14.2.2. Intestine

        14.2.3. Liver

        14.2.4. Pancreas

        14.2.5. Lung

        14.2.6. Brain

        14.2.7. Kidney

        14.2.8. Others

    14.3. Middle East & Africa Organoids Market Value Forecast, by Application, 2018–2030

        14.3.1.  Developmental Biology

        14.3.2. Disease Pathology of Infectious Disease

        14.3.3. Regenerative Medicine

        14.3.4. Drug Toxicity & Efficacy Testing

        14.3.5. Drug Discovery & Personalized Medicine

        14.3.6. Others

    14.4. Middle East & Africa Organoids Market Value Forecast, by Source, 2018–2030

        14.4.1. Pluripotent Stem Cells (hIPSCs)

        14.4.2. Organ-speci?c Adult Stem Cells (ASCs)

    14.5. Middle East & Africa Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Organoids Market Attractiveness Analysis

        14.6.1. By Type

        14.6.2. By Application

        14.6.3. By Source

        14.6.4. By Country/Sub-region

15. Competitive Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2.  Company Profiles

        15.2.1.STEMCELL Technologies, Inc.

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Product Portfolio

            15.2.1.3. Strategic Overview

            15.2.1.4. SWOT Analysis

        15.2.2.Cellesce Ltd

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Product Portfolio

            15.2.2.3. Strategic Overview

            15.2.2.4. SWOT Analysis

        15.2.3. Hubrecht Organoid Technology

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Product Portfolio

            15.2.3.3. Strategic Overview

            15.2.3.4. SWOT Analysis

        15.2.4.Definigen

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Product Portfolio

            15.2.4.3. Strategic Overview

            15.2.4.4. SWOT Analysis

        15.2.5.3Dnamics, Inc.

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Product Portfolio

            15.2.5.3. Strategic Overview

            15.2.5.4. SWOT Analysis

        15.2.6.Organoid Therapeutics

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Product Portfolio

            15.2.6.3. Strategic Overview

            15.2.6.4. SWOT Analysis

        15.2.7. PeproTech, Inc.

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Product Portfolio

            15.2.7.3. Strategic Overview

            15.2.7.4. SWOT Analysis

        15.2.8. Thermo Fisher Scientific

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Financial Overview

            15.2.8.3. Product Portfolio

            15.2.8.4. Strategic Overview

            15.2.8.5. SWOT Analysis

        15.2.9.Corning Incorporated (Life Sciences)

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Financial Overview

            15.2.9.3. Product Portfolio

            15.2.9.4. Strategic Overview

            15.2.9.5. SWOT Analysis

        15.2.10. Merck KGgA

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Financial Overview

            15.2.10.3. Product Portfolio

            15.2.10.4. Strategic Overview

            15.2.10.5. SWOT Analysis

List of Tables

Table 01: Global Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
 Table 02: Global Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
 Table 03: Global Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
 Table 04: Global Organoids Market Value (US$ Mn) Forecast, by Region, 2018–2030
 Table 05: North America Organoids Market Value (US$ Mn) Forecast, by Country, 2018–2030
 Table 06: North America Organoids Market Value Forecast, by Type, 2018–2030
 Table 07: North America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
 Table 08: North America Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
 Table 09: Europe Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
 Table 10: Europe Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
 Table 11: Europe Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
 Table 12: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
 Table 13: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
 Table 14: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
 Table 15: Latin America Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
 Table 16: Latin America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
 Table 17: Latin America Organoids  Market Value (US$ Mn) Forecast, by Source, 2018–2030
 Table 18: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
 Table 19: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
 Table 20: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030

List of Figures


Figure 01: Global Organoids Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Organoids Market Value Share, by Type, 2019
Figure 03:Global Organoids Market Value Share, by Application, 2019
 Figure 04: Global Organoids Market Value Share, by Source, 2019
 Figure 05: Global Organoids Market Value Share Analysis, by Type, 2019 and 2030
 Figure 06: Global Organoids Market Value (US$ Mn), by Stomach, 2018–2030
 Figure 07: Global Organoids Market Value (US$ Mn), by Intestine, 2018–2030
 Figure 08: Global Organoids Market Value (US$ Mn), by Liver, 2018–2030
 Figure 09: Global Organoids Market Value (US$ Mn), by Pancreas, 2018–2030
Figure 10: Global Organoids Market Value (US$ Mn), by Lung, 2018–2030
Figure 11: Global Organoids Market Value (US$ Mn), by Brain, 2018–2030
Figure 12: Global Organoids Market Value (US$ Mn), by Kidney, 2018–2030
Figure 13: Global Organoids Market Value (US$ Mn), by Others , 2018–2030
Figure 14: Global Organoids Market Attractiveness Analysis, by Type, 2020–2030
 Figure 15: Global Organoids Market Value Share Analysis, by Application, 2019 and 2030
 Figure 16: Global Organoids Market Value (US$ Mn), by Developmental Biology , 2018–2030
 Figure 17: Global Organoids Market Value (US$ Mn), by Disease Pathology of Infectious Disease, 2018–2030
 Figure 18: Global Organoids Market Value (US$ Mn), by Regenerative Medicine, 2018–2030
 Figure 19: Global Organoids Market Value (US$ Mn), by Drug Toxicity & Efficacy Testing, 2018–2030
Figure 20: Global Organoids Market Value (US$ Mn), by Drug Discovery & Personalized Medicine, 2018–2030
Figure 21: Global Organoids Market Value (US$ Mn), by Others, 2018–2030
 Figure 22: Global Organoids Market Attractiveness Analysis, by Application, 2020–2030
 Figure 23: Global Organoids Market Value Share Analysis, by Source, 2019 and 2030
 Figure 24: Global Organoids Market Value (US$ Mn), by Pluripotent Stem Cells (hIPSCs), 2018–2030
 Figure 25: Global Organoids Market Value (US$ Mn), by Organ-speci?c Adult Stem Cells (ASCs),2018–2030
 Figure 26: Global Organoids Market Attractiveness Analysis, by Source, 2020–2030
 Figure 27 : Global Organoids Market Value Share Analysis, by Region, 2019 and 2030
 Figure 28 : Global Organoids Market Attractiveness Analysis, by Region, 2020–2030
 Figure 29: North America Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
 Figure 30: North America Organoids Market Value Share (%), by Country, 2019 and 2030
 Figure 31: North America Organoids Market Attractiveness Analysis, by Country, 2020–2030
 Figure 32: North America Organoids Market Value Share (%), by Type, 2019 and 2030
 Figure 33: North America Organoids Market Attractiveness Analysis, by Type, 2020–2030
 Figure 34: North America Organoids Market Value Share (%), by Application, 2019 and 2030
 Figure 35: North America Organoids Market Attractiveness Analysis, by Application, 2020–2030
 Figure 36: North America Organoids Market Value Share (%), by Source, 2019 and 2030
 Figure 37: North America Organoids Market Attractiveness Analysis, by Source, 2020–2030
 Figure 38: Europe Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
 Figure 39: Europe Organoids Market Value Share (%), by Country/Sub-region, 2019 and 2030
 Figure 40: Europe Organoids Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
 Figure 41: Europe Organoids Market Value Share (%), by Type, 2019 and 2030
 Figure 42: Europe Organoids Market Attractiveness Analysis, by Type, 2020–2030
 Figure 43: Europe Organoids Market Value Share (%), by Application, 2019 and 2030
 Figure 44: Europe Organoids Market Attractiveness Analysis, by Application, 2020–2030
 Figure 45: Europe Organoids Market Value Share (%), by Source, 2019 and 2030
 Figure 46: Europe Organoids Market Attractiveness Analysis, by Source, 2020–2030
 Figure 47: Asia Pacific Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
 Figure 48: Asia Pacific Organoids Market Value Share (%), by Country/Region, 2019 and 2030
 Figure 49: Asia Pacific Organoids Market Attractiveness Analysis, by Country/Region, 2020–2030
 Figure 50: Asia Pacific Organoids Market Value Share (%), by Type, 2019 and 2030
 Figure 51: Asia Pacific Organoids Market Attractiveness Analysis, by Type, 2020–2030
 Figure 52: Asia Pacific Organoids Market Value Share (%), by Application, 2019 and 2030
 Figure 53: Asia Pacific Organoids Market Attractiveness Analysis, by Application, 2020–2030
 Figure 54: Asia Pacific Organoids Market Value Share (%), by Source, 2019 and 2030
 Figure 55: Asia Pacific Organoids Market Attractiveness Analysis, by Source, 2020–2030
 Figure 56: Latin America Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
 Figure 57: Latin America Organoids Market Value Share (%), by Country/Region, 2019 and 2030
 Figure 58: Latin America Organoids Market Attractiveness Analysis, by Country/Region, 2020–2030
 Figure 59: Latin America Organoids Market Value Share (%), by Type, 2019 and 2030
 Figure 60: Latin America Organoids Market Attractiveness Analysis, by Type, 2020–2030
 Figure 61: Latin America Organoids Market Value Share (%), by Application, 2019 and 2030
 Figure 62: Latin America Organoids Market Attractiveness Analysis, by Application, 2020–2030
 Figure 63: Latin America Organoids Market Value Share (%), by Source, 2019 and 2030
 Figure 64: Latin America Organoids Market Attractiveness Analysis, by Source, 2020–2030
 Figure 65: Middle East & Africa Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
 Figure 66: Middle East & Africa Organoids Market Value Share (%), by Country/Region, 2019 and 2030
 Figure 67: Middle East & Africa Organoids Market Attractiveness Analysis, by Country/Region, 2020–2030
 Figure 68: Middle East & Africa Organoids Market Value Share (%), by Type, 2019 and 2030
 Figure 69: Middle East & Africa Organoids Market Attractiveness Analysis, by Type, 2020–2030
 Figure 70: Middle East & Africa Organoids Market Value Share (%), by Application, 2019 and 2030
 Figure 71: Middle East & Africa Organoids Market Attractiveness Analysis, by Application, 2020–2030
 Figure 72: Middle East & Africa Organoids Market Value Share (%), by Source, 2019 and 2030
 Figure 73: Middle East & Africa Organoids Market Attractiveness Analysis, by Source, 2020–2030

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

639

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved